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Background: Postoperative pancreatic fistula (POPF) is regarded as the most serious complication of
pancreatic surgery. The preoperative risk stratification of patients by simple means is of interest in
perioperative clinical management.
Methods: Based on prospective data, we performed a risk factor analysis for POPF after pancre-
atoduodenectomy in 62 patients operated between 2006 and 2008 with special focus on clinical param-
eters that might serve to predict POPF. A predictive score was developed and validated in an independent
second dataset of 279 patients operated between 2001 and 2010.
Results: Several pre- and intraoperative factors, as well as underlying pathology, showed significant
univariate correlation with rate of POPF. Multivariate analysis (binary logistic regression) disclosed soft
pancreatic texture (odds ratio [OR] 10.80, 95% confidence interval [CI] 1.80–62.20) and history of weight
loss (OR 0.15, 95% CI 0.04–0.66) to be the only independent preoperative clinical factors influencing
POPF rate. The subjective assessment of pancreatic hardness by the surgeon correlated highly with
objective assessment of pancreatic fibrosis by the pathologist (r = -0.68, P < 0.001, two-tailed Spear-
man's rank correlation). A simple risk score based on preoperatively available clinical parameters was
able to stratify patients correctly into three risk groups and was independently validated.
Conclusions: Preoperative stratification of patients regarding risk for POPF by simple clinical param-
eters is feasible. Pancreatic texture, as evaluated intraoperatively by the surgeon, is the strongest single
predictive factor of POPF. The findings of the study may have important implications for perioperative risk
assessment and patient care, as well as for the choice of anastomotic techniques.
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Introduction
Postoperative pancreatic fistula (POPF) is generally regarded as
the most relevant complication after pancreatoduodenectomy
(PD) because it potentially leads to deleterious secondary compli-
cations, increased health care costs and prolonged hospital stay.1–3
Recent studies using the strict definition applied by the Inter-
national Study Group of Pancreatic Surgery (ISGPS)3 report
POPF rates of around 30%.1–4 Many risk factors for the develop-
ment of POPF have been identified and anastomotic techniques
have been refined in multiple ways in an effort to minimize POPF
rates. This sometimes leads to the use of special anastomotic tech-
niques or perioperative precautions.4–8 As multiple studies have
not elucidated which factor has the highest predictive value, it*These authors contributed equally.
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remains of particular importance to evaluate pre- and intraopera-
tive parameters which can predict the rate of POPF in order to
identify patients at risk for POPF formation. This problem is of
particular relevance when studies are designed to evaluate varying
operative reconstructive techniques after pancreatic resection or
the use of therapies that pharmacologically aim to reduce pancre-
atic fistula formation, such as sandostatin.
This study was designed as an objective, prospective evalua-
tion of the importance of the hardness and fibrosis of the pan-
creatic remnant for the development of pancreatic fistula after
PD using histological analysis of the fibrosis grade of the pan-
creas. Furthermore, we evaluated whether subjective evaluation
of pancreatic hardness by an experienced pancreatic surgeon is
as accurate as postoperative histopathological assessment by a
pathologist in predicting POPF rate. The findings of the study
may have important implications for perioperative risk assess-
ment, postoperative patient care and, potentially, choice of anas-
tomotic technique.
Materials and methods
Patients, data and statistics
We sourced our material from a prospectively maintained data-
base of patients undergoing pancreatic surgery from 1994 at the
Department of General and Visceral Surgery, University Hospital
Freiburg, Freiburg, Germany, with the approved of the hospital
ethics committee. A total of 62 consecutive patients were included
in the study for risk factor analysis and the development of a
preoperative risk score. To validate the risk score, we used preop-
erative and POPF data for an independent dataset of 279 patients
operated at the Department of General and Visceral Surgery
between 2001 and 2010. The risk score was calculated retrospec-
tively after the review of patient records. Collection of data and
statistics were performed using spss Version 17.0 (SPSS, Inc.,
Chicago, IL, USA). For statistical analysis, descriptive measures,
Spearman’s rank correlation, Fisher’s exact test, Mann–Whitney
U-test and binary logistic regression with stepwise backward
elimination were employed as indicated at a significance level of
0.05.
Operations and standard postoperative care
The standard operation was a pylorus-preserving PD with a
reconstruction by pancreatogastrostomy (PG) or pancreatojejun-
ostomy (PJ). Two soft silicon drains were placed near the pancre-
atic anastomosis and routinely removed on day 5 when no POPF
was evident from the drain effluate. Two additional drains were
placed next to the hepaticojejunostomy. Patients were treated on
the intermediate care unit for at least 2 days before transfer to a
normal ward. To detect every grade A POPF according to ISGPS
definitions, amylase levels in the drain fluid were measured daily
for at least the first 3 postoperative days. Amylase levels were also
evaluated on every occasion fluid was obtained by puncture or
drainage of intra-abdominal collections. Sandostatin was admin-
istered only if drain amylase activity exceeded 1000 U/l on post-
operative day 3. The use of sandostatin was documented and
included in the analysis.
Definition of POPF
Postoperative pancreatic fistula was defined according to the
ISGPS definition: a POPF is present if amylase level on or after
postoperative day 3 exceeds three times the upper serum limit.
Briefly, grading of POPF is dependent on the clinical course: grade
A POPF does not need specific treatment; grade B POPF requires
prolonged drainage or specific medical treatment, and grade C
POPF requires invasive therapy.3
Assessment of risk factors for POPF
Demographic data and co-morbidity were retrieved from the data-
base, as well as data concerning known risk factors for the devel-
opment of POPF.9–22 Weight loss (3 kg over the previous 6
months) was assessed by patient interview for the 6 months before
the operation. The following risk factors were assessed during the
operation: pancreatic texture; duct diameter (measured with a
scale at the cut surface); mobilization of the pancreatic remnant,
and involvement of the uncinate process by the tumour or inflam-
matorymass. Twomethods were used to quantify pancreatic hard-
ness. Firstly, the pancreatic remnant was evaluated subjectively
during the operation. The degree of pancreatic fibrosis (soft/hard)
in the pancreatic remnant was evaluated subjectively by one expe-
rienced pancreatic surgeon (TK) during the operation as ‘hard’ or
‘soft’. Secondly, haematoxylin and eosin-stained tissue sections
from the pancreatic cut surface were evaluated retrospectively by
an experienced pathologist (GK) blinded to the intraoperative
evaluation and the postoperative clinical course. Histological
evaluation of pancreatic parenchyma at the resection margin was
performed using the following four-stage scoring system:
0 = normal pancreas parenchyma, no fibrotic changes; 1 = mild
fibrosis with thickening of periductal fibrous tissue; 2 = moderate
fibrosis with marked sclerosis of interlobular septa, no evidence of
architectural changes, and 3 = severe fibrosis with detection of
architectural destruction. For univariate and multivariate risk
factor analysis,POPF (gradeA,BorC)was defined as the endpoint.
Results
A total of 62 consecutive patients who underwent partial PD
between 2006 and 2008 were included in the study. Patient char-
acteristics, operative findings and procedures and final histology
are shown in Table 1. Factors showing a significant correlation
with the development of POPF are also depicted in Table 1.
Higher age was a risk factor for the development of POPF, whereas
history of weight loss and history of pancreatitis constituted pro-
tective factors. Intraoperative risk factors for POPF were soft pan-
creatic texture as evaluated by the surgeon, more extensive
mobilization of the pancreatic remnant and small duct diameter.
Involvement of the uncinate process by the underlying disease was
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associated with less POPF. Regarding histopathological diagnoses,
patients suffering from pancreatic carcinoma and chronic pancre-
atitis had lower rates of POPF compared with patients with other
pathologies.
All preoperatively or intraoperatively available parameters that
correlated significantly with the POPF rate (Table 1) were included
in a multivariate binary logistic regression model. The only inde-
pendent factors identified by this approachwere pancreatic texture
and history of weight loss prior to the operation. Soft pancreatic
texture, as assessed by the surgeon intraoperatively, was the stron-
gest predictor for POPF (Tables 1 and 2). There was also a strong
correlation of soft pancreatic texture with lower histopathological
grade of pancreatic fibrosis at the cut surface (Table 2).
Univariate correlation analysis was performed to identify the
factors associated with hard pancreatic texture (Table 3). There
was significant association between hard pancreatic texture and
Table 1 Patient and surgery-based parameters and univariate and multivariate analysis of risk factors for the occurrence of postoperative
pancreatic fistula (grades A–C)
Parameter description n or median (range) in groups Univariate analysis Multivariate analysis












Age, years 66 (39–84) 65 (39–84) 71 (40–84) +0.27 0.038 1.01 (0.94–1.09) 0.739
Sex, male : female 30:32 21:22 9:10 +0.14 0.917
BMI 23 (16–34) 23 (16–30) 24 (19–34) +0.14 0.296
Preoperative ERD 27 (43.5%) 20 7 -0.09 0.487
Preoperative PTD 4 (6.5%) 4 0 -0.18 0.175
Preoperative bilirubin, mg/dl 1.4 (0.2–37.4) 1.6 (0.2–37.4) 0.9 (0.3–24.7) -0.11 0.410
Diabetes mellitus 9 (14.5%) 6 3 +0.02 0.853
Cardiac disease 13 (21.0%) 7 6 +0.17 0.178
Renal disease 5 (8.1%) 2 3 +0.19 0.142
Preoperative creatinine, mg/dl 0.8 (0.5–2.2) 0.8 (0.5–2.2) 0.9 (0.5–2.1) +0.13 0.313
Pulmonary disease 7 (11.3%) 4 3 +0.10 0.465
History of weight loss, yes 38 (61.3%) 32 6 -0.41 0.001 0.15 (0.03–0.69) 0.015
History of acute pancreatitis 9 (14.5%) 9 0 -0.27 0.031 0.00 (0–•) 0.999
Reported active smoking 18 (29.0%) 14 4 -0.12 0.366
Reported pack-years 0 (0–80) 0 (0–80) 0 (0–46) -0.11 0.411
Reported alcohol abuse 2 (3.2%) 2 0 -0.12 0.347
Operations and intraoperative parameters
Classical Whipple procedure 4 (6.5%) 2 2 +0.11 0.394
Portal venous resection 11 (17.7%) 8 3 -0.34 0.793
Operation time, h 7.6 (4.7–11.4) 7.6 (5.1–11.4) 7.6 (4.7–11.2) -0.03 0.809
Blood loss, l 0.5 (0.2–2) 0.5 (0.2–2) 0.5 (0.2–1.5) +0.57 0.663
Pancreatic texture soft (evaluation by surgeon) 33 (53.2%) 16 17 +0.48 0.000 10.18 (1.26–82.39) 0.030
Mobilization of pancreatic remnant, cm 3 (2–5) 2.5 (2–5) 3 (2–4) +0.31 0.014 1.60 (0.62–4.08) 0.329
Pancreatic duct diameter, mm 3 (2–10) 4 (2–10) 3 (2–8) -0.30 0.018 0.94 (0.58–1.54) 0.809
Involvement of the uncinate process 21 (33.8%) 18 3 -0.25 0.046 0.46 (0.07–2.84) 0.402
Histopathology
Pancreatic carcinoma 27 (43.5%) 24 3 -0.37 0.003
Chronic pancreatitis 7 (11.3%) 6 1 -0.13 0.327
Ampullary carcinoma 11 (17.7%) 6 5 +0.15 0.247
Cholangiocellular carcinoma 4 (6.5%) 1 3 +0.25 0.048
Cystic neoplasia of the pancreas 4 (6.5%) 2 2 +0.11 0.394
Duodenal carcinoma 3 (4.8%) 2 1 +0.01 0.919
Neuroendocrine tumour 2 (3.2%) 1 1 +0.08 0.554
Other 4 (6.5%) 1 3 +0.25 0.048
Univariate analysis: two-tailed Spearman's rank correlation; negative values in correlation coefficient indicate protective factors and positive values
indicate risk factors
Multivariate analysis: binary logistic regression
POPF, postoperative pancreatic fistula (International Study Group for Pancreatic Surgery definition); 95% CI, 95% confidence interval; ERD,
endoscopic retrograde drainage; PTD, percutaneous transhepatic drainage; BMI, body mass index; CNP, cystic neoplasia of the pancreas; NET,
neuroendocrine tumour
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large duct diameter, involvement of the uncinate process, pancre-
atic carcinoma and chronic pancreatitis, whereas ampullary car-
cinoma was generally associated with a soft pancreas.Younger age,
history of acute pancreatitis, active smoking and increasing
number of pack-years also showed significant correlations with
hard pancreatic texture.
Preoperative evaluation of risk for POPF by
clinical parameters
On the basis of the aforementioned findings, a preoperative risk
score for use in the clinic was developed. Factors available preop-
eratively that had been found to correlate with risk for POPF
(Table 1) and parameters that showed significant correlation with
pancreatic texture (Table 3) were included. For simplicity, the
score was calculated by adding 1 point for a risk factor and sub-
tracting 1 point for a protective factor (Table 4). Preoperative
diagnosis was presumed to be pancreatic carcinoma or chronic
pancreatitis unless specific preoperative findings (history;
imaging by computed tomography, magnetic resonance imaging
[MRI] or endoscopic retrograde cholangiopancreatography; pre-
operative histology) supported another diagnosis such as ampul-
lary carcinoma, bile duct cancer, cystic or neuroendocrine
tumours of the pancreas or metastasis to the pancreas. As shown
in Table 4, the risk score could distinguish significantly between a
low-risk group of patients who developed no POPF, a medium-
risk group with a 27% POPF rate, and a high-risk group with a
61% POPF rate (correlation coefficient = 0.47, P < 0.001 for two-
tailed Spearman’s rank correlation).
Validation of the preoperative risk score
An independent dataset comprising 279 patients was used to vali-
date the newly developed risk score. As Table 4 shows, the score
could correctly distinguish the three risk categories. These corre-
lations were highly significant (correlation coefficient = 0.35,
P < 0.001 for two-tailed Spearman’s rank correlation).
Discussion
From the earliest days of pancreatic surgery to the most recent
clinical series, pancreatic secretions and POPF have been recog-
nized as the main determinants of morbidity.2,17,23–25 Despite the
long history of this ‘Achilles heel’ in pancreatic surgery, an inter-
national consensus definition of POPF has only recently been
introduced by the ISGPS.3 The significant impact of POPF on
health care costs has also been recently demonstrated.1
In an attempt to predict the development of POPF, clinical
studies have identified many risk factors, such as gender,9 cardio-
vascular disease,9,10 diabetes mellitus,9 obesity,11 leukocytosis,12
low serum albumin,12 impaired renal function,13 centre effect,14
underlying pathology,9,15–18 long operative time,9 concomitant
surgery or radical lymphadenectomy,9,15 high intraoperative
blood loss,9,17,19 small pancreatic duct diameter15,17,20 and ‘fatty’26
or ‘soft’10,14,15,17,19–22 pancreas. The latter has been described as a risk
factor for the development of POPF in several series of pancreatic
Table 2 Correlation of soft pancreatic texture with occurrence of postoperative pancreatic fistula and low histopathological fibrosis grade
Pancreatic texture Occurrence of postoperative pancreatic fistula (ISGPS definition)
No POPF POPF grade A POPF grade B POPF C
Soft 16 11 2 4
Hard 27 1 1 0
Correlation coefficient = 0.47, P < 0.001a
Pancreatic texture Histopathological fibrosis grade
0 1 2 3
Soft 6 13 10 2
Hard 0 0 13 14
Correlation coefficient = -0.68,P < 0.001a
Pancreatic texture as assessed by the operating surgeon
Numbers are actual numbers of patients
aCorrelation coefficient and P-value for two-tailed Spearman's rank correlation
POPF, postoperative pancreatic fistula; ISGPS, International Study Group for Pancreatic Surgery
Table 3 Conditions correlating to hard pancreatic texture
Parameter Correlation coefficient P-value
Age, years -0.34 0.007
History of acute pancreatitis +0.26 0.045





Involvement of the uncinate
process
+0.29 0.025
Pancreatic carcinoma +0.48 0.000
Chronic pancreatitis +0.28 0.028
Ampullary carcinoma -0.44 0.000
Two-tailed Spearman's rank correlation
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surgery since the 1970s.21,24,25,27–31 Some prospective trials in pan-
creatic surgery have acknowledged this by stratifying patients for
randomization or final analysis.16,32–34
In this study, patient characteristics were prospectively evalu-
ated as risk factors for POPF. Univariate analysis identified several
risk or protective factors for POPF. Multivariate analysis disclosed
that only preoperative weight loss and hard pancreatic texture
were independent predictive factors. Prediction by the surgeon
was the most reliable of all evaluated parameters. There was also a
very strong correlation between the grade of hardness assessed
subjectively by the surgeon and the grade of pancreatic fibrosis
assessed objectively by the pathologist. Although every experi-
enced pancreatic surgeon is familiar with this correlation, few
studies have examined it scientifically.35
Furthermore, other factors that may predict the development of
pancreatic fistula formation after partial PD were assessed. Preop-
erative weight loss was found to be a protective factor in the
current analysis, which, to the authors’ knowledge, has not been
identified in previous studies. This finding may be explained by a
positive correlation between body mass index (BMI) and pancre-
atic fat in previous studies,26,36 as increased BMI11 and pancreatic
fat26 are risk factors for POPF. These earlier studies did not corre-
late pancreatic fat with tissue hardness and thus it remains
unproven whether the so-called fatty pancreas would be judged as
soft by the surgeon. By contrast, weight loss is a typical feature of
pancreatic carcinoma, which is usually associated with a hard
pancreas and safer anastomosis.
In addition, episodes of acute pancreatitis contributed to pan-
creatic hardness. The negative correlation of pancreatic hardness
with age may be explained by increasing pancreatic fat with age.26
Interestingly, this study is the first to identify an influence of
smoking on pancreatic texture. Both active smoking and number
of pack-years correlated with the development of a hard pancreas.
This is consistent with the experimental finding that tobacco
smoke induces inflammatory lesions in the pancreas of rats.37
Among intraoperative factors, mobilization of the pancreatic
remnant is noteworthy because it is the only factor that can be
influenced by the surgeon. Extensive mobilization resulted in a
higher rate of POPF.
In concordance with previous studies,9,15–18 pancreatic texture
was hard in chronic pancreatitis and pancreatic carcinoma and
soft in cases of smaller ampullary carcinoma. However, histo-
pathological diagnosis cannot be used for prospective and preop-
erative risk assessment.
Table 4 Calculation of the preoperative risk score and correlation to the occurrence of postoperative pancreatic fistula
Factor Value
Age >66 years +1
Preoperative diagnosis other than pancreatic carcinoma or chronic pancreatitis +1
History of smoking -1
History of weight loss -1
History of acute pancreatitis -1
Sum score High risk: sum of 1 or 2
Medium risk: sum of -1 or 0
Low risk: sum of -3 or -2
POPF grade Training dataset Validation dataset
Preoperative risk score Preoperative risk score
Low Medium High Low Medium High
None 14 22 7 43 117 15
100.0% 73.3% 38.9% 78.2% 70.1% 26.3%
A 0 5 7 8 27 20
0.0% 16.7% 38.9% 14.5% 16.2% 35.1%
B 0 1 2 1 11 6
0.0% 3.3% 11.1% 1.8% 6.6% 10.5%
C 0 2 2 3 12 16
0.0% 6.7% 11.1% 5.5% 7.2% 28.1%
Correlation coefficient = 0.47 Correlation coefficient = 0.35
P < 0.001a P < 0.001a
The score was developed in the ‘training’ dataset of 62 patients and validated in an independent dataset of 279 patients
Numbers given are absolute and percentages refer to the total number of patients in one column
aCorrelation coefficient and P-value for two-tailed Spearman's rank correlation
POPF, postoperative pancreatic fistula, Grades A–C according to International Study Group for Pancreatic Surgery definitions
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What makes a soft pancreas so dangerous? Many surgeons like
to point out the technical difficulties of a pancreatoenteric anas-
tomosis. Obviously, soft tissue cannot resist the tearing forces of
sutures as reliably as hard tissue. By contrast, a soft parenchyma is,
as in our study, often associated with a small, non-dilated pancre-
atic duct, which makes the popular duct-to-mucosa anastomosis
difficult or even impossible. A sometimes neglected aspect is the
degree of preserved exocrine pancreatic function in the individual
patient, which cannot be influenced by the surgeon. A soft paren-
chyma and non-dilated pancreatic duct have been shown to
be associated with well-preserved exocrine pancreatic func-
tion,22,30,31,38,39 thereby representing an important reason for the
development of POPF.
Given the tremendous importance of pancreatic texture in pan-
creatic surgery, substantial effort has been devoted to finding ways
of obtaining objective measurements of pancreatic hardness.
Intraoperative use of a durometer has been proposed for the
evaluation of pancreatic hardness.35,40 Preoperative assessment of
pancreatic texture is possible by means of dynamic MRI8,18 and
preoperative tests of exocrine pancreatic function.30,41 However,
radiodensity of the pancreas did not correlate with pancreatic
hardness or fibrosis.35 These reported methods are cumbersome
or expensive and are unlikely to be applied in larger series. By
contrast, careful evaluation of patient history and intraoperative
risk factors represents a reliable way of risk prediction at no cost.
This study has demonstrated a clinical risk score which can be
easily calculated from the patient’s history and which has been
validated against a large independent dataset. This risk score was
able to distinguish between three risk groups, showing rates of
around 6% for clinically relevant POPF (grade B or C) in the
low-risk group and almost 40% for relevant POPF in the high-risk
group. The strongest single, yet only intraoperatively available,
predictor remains pancreatic texture as evaluated by the experi-
enced surgeon, which showed POPF rates of around 50% in cases
of soft pancreas and only 6% in cases of hard pancreas. No grade
C fistula was seen in patients with a hard pancreas.
In order to reduce the POPF rate in high-risk patients with a
soft pancreas, various operative procedures have been described
since the first large series of PD. Techniques that use some form
of invagination in either PJ or PG or techniques using duct
ligation and drainage have been reported to be especially
beneficial.42–44 Some surgeons have even suggested performing
total pancreatectomy in cases of very soft pancreas,25,35,45 an
approach that we do not generally support, given the broad
armamentarium of safe reconstructive techniques. A recent pro-
spective study14 comparing two techniques of PJ demonstrated
that pancreatic technique represents a strong bias when compar-
ing anastomotic techniques. By contrast with the trial hypoth-
esis, the authors found the invagination method to be superior
in terms of POPF rate. This difference was only obvious after
stratification for pancreatic texture. At our institution, a ran-
domized trial is currently ongoing to test whether PG leads to a
reduced POPF rate in comparison with PJ. With regard to non-
operative measures, preoperative octreotide treatment has been
shown to harden the pancreas5,40 and may reduce POPF rates in
high-risk patients.6,7
In summary, pancreatic texture represents a highly significant
determinant of pancreatoenteric anastomotic leakage rates and
corresponds to the degree of pancreatic fibrosis and exocrine
function. Careful evaluation of patient history and intraoperative
assessment of pancreatic texture by the surgeon are the most
simple yet very reliable methods of preoperative and intraopera-
tive prediction of risk for POPF. The currently proposed clinical
risk score needs to be prospectively evaluated. Measures that may
reduce POPF rates in high-risk patients are choice of pancrea-
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